Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–26.

Article  CAS  PubMed  Google Scholar 

Iftikhar R, Chaudhry QUN, Anwer F, Neupane K, Rafae A, Mahmood SK, et al. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies. Blood Rev. 2021;47: 100772.

Article  CAS  PubMed  Google Scholar 

Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, et al. Variation in supportive care practices in hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008;14:1231–8.

Article  PubMed  PubMed Central  Google Scholar 

Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, et al. Individual physician practice variation in hematopoietic cell transplantation. J Clin Oncol. 2008;26:2162–70.

Article  PubMed  Google Scholar 

Pidala J, Lee SJ, Quinn G, Jim H, Kim J, Anasetti C. Variation in management of immune suppression after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011;17:1528–36.

Article  PubMed  PubMed Central  Google Scholar 

Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K, et al. The EBMT activity survey 2008: impact of team size, team density and new trends. Bone Marrow Transplant. 2011;46:174–91.

Article  CAS  PubMed  Google Scholar 

Majhail NS, Mau L-W, Chitphakdithai P, Denzen EM, Joffe S, Lee SJ, et al. Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transplant. 2020;55:906–17.

Article  PubMed  Google Scholar 

Matsuo K, Hamajima N, Morishima Y, Harada M. Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan society for hematopoietic cell transplantation. Bone Marrow Transplant. 2000;26:1061–7.

Article  CAS  PubMed  Google Scholar 

Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, et al. Comparison of outcomes of 8/8 and 7/8 allele-matched unrelated bone marrow transplantation and single-unit cord blood transplantation in adults with acute leukemia. Biol Blood Marrow Transplant. 2016;22:330–8.

Article  PubMed  Google Scholar 

Kanda J, Hayashi H, Ruggeri A, Kimura F, Volt F, Takahashi S, et al. Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study. Leukemia. 2020;34:128–37.

Article  CAS  PubMed  Google Scholar 

Mesnil F, Jouet J-P, Tuppin P, Vernant J-P, Golmard J-L. Evaluation of centre and period effects in allogeneic haematopoietic stem cell transplantation in France. Bone Marrow Transplant. 2004;34:645–51.

Article  CAS  PubMed  Google Scholar 

Klingebiel T, Cornish J, Labopin M, Locatelli F, Darbyshire P, Handgretinger R, et al. Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the acute Leukemia and pediatric disease working parties of the European blood and marrow transplant group. Blood. 2010;115:3437–46.

Article  CAS  PubMed  Google Scholar 

Yanada M, Yano S, Kuwatsuka Y, Kawamura K, Fukuda T, Ichinohe T, et al. The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia. Bone Marrow Transplant. 2024;59:541–9.

Article  PubMed  Google Scholar 

Kurosawa S, Fukuda T, Ichinohe T, Hashii Y, Kanda J, Goto H, et al. Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia. Cytotherapy. 2024;26:1185–92.

Article  PubMed  Google Scholar 

Shimomura Y, Kitamura T, Murata M, Matsuo K, Ito Y, Ichinohe T, et al. Impact of center volume on chronic graft versus host disease in patients with allogeneic stem cell transplantation. Transplant Cell Ther. 2024;30:326.e1-326.e14.

Article  CAS  PubMed  Google Scholar 

Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Acute graft-versus-host disease. Nat Rev Dis Primer. 2023;9:27.

Article  Google Scholar 

Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European society for blood and marrow transplantation. Lancet Haematol. 2020;7:e157–67.

Article  PubMed  Google Scholar 

Ponce DM, Hilden P, Mumaw C, Devlin SM, Lubin M, Giralt S, et al. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 2015;125:199–205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92:2303–14.

CAS  PubMed  Google Scholar 

Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96:2062–8.

CAS  PubMed  Google Scholar 

Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR, et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol. 2009;10:855–64.

Article  CAS  PubMed  Google Scholar 

Bolwell B, Sobecks R, Pohlman B, Andresen S, Rybicki L, Kuczkowski E, et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;34:621–5.

Article  CAS  PubMed  Google Scholar 

Bacigalupo A, Milone G, Cupri A, Severino A, Fagioli F, Berger M, et al. Steroid treatment of acute graft- versus -host disease grade I: a randomized trial. Haematologica. 2017;102:2125–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mielcarek M, Storer B, Boeckh M, Carpenter P, McDonald G, Deeg H, et al. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood. 2009;113(13):2888–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hockenbery DM, Cruickshank S, Rodell TC, Gooley T, Schuening F, Rowley S, et al. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood. 2007;109:4557–63.

Article  CAS  PubMed  Google Scholar 

Martin PJ. How I treat steroid-refractory acute graft-versus-host disease. Blood. 2020;135:1630–8.

Article  PubMed  Google Scholar 

Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–8.

CAS  PubMed  Google Scholar 

Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250–9.

CAS  PubMed  Google Scholar 

Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimomura Y, Kitamura T, Sugita J, Terao T, Satake A, Hirakawa T, et al. Impact of donor type on the outcomes of acute graft versus host disease to systemic corticosteroid therapy. Bone Marrow Transplant. 2024;59:1763–72.

Article  CAS  PubMed  Google Scholar 

Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2009;15:367–9.